General Statement of Disclosure: CONSULTING FEES/HONORARIA: Eidos(MODEST), Pfizer(MODEST), Ionis(MODEST), Alnylam(MODEST), Novo Nordisk Inc.(MODEST), Arbor Biotechnologies(SIGNIFICANT) View Full Disclosure